These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 34478754)
21. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies. Schenck L; Erdemir D; Saunders Gorka L; Merritt JM; Marziano I; Ho R; Lee M; Bullard J; Boukerche M; Ferguson S; Florence AJ; Khan SA; Sun CC Mol Pharm; 2020 Jul; 17(7):2232-2244. PubMed ID: 32392068 [TBL] [Abstract][Full Text] [Related]
22. Small-Scale Continuous Drug Product Manufacturing using Dropwise Additive Manufacturing and Three Phase Settling for Integration with Upstream Drug Substance Production. Sundarkumar V; Nagy ZK; Reklaitis GV J Pharm Sci; 2022 Aug; 111(8):2330-2340. PubMed ID: 35341723 [TBL] [Abstract][Full Text] [Related]
23. [Current status, trends, and challenges of continuous manufacturing technology for oral traditional Chinese medicine solid preparations]. Wang ZQ; Wang XC; Zhong ZJ; Liu ZF; Wang YQ; Yi B; Yang M; Zhu WF; Wu ZF Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4536-4544. PubMed ID: 37802880 [TBL] [Abstract][Full Text] [Related]
24. 3D printing for personalised medicines: implications for policy and practice. Englezos K; Wang L; Tan ECK; Kang L Int J Pharm; 2023 Mar; 635():122785. PubMed ID: 36849040 [TBL] [Abstract][Full Text] [Related]
25. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Norman J; Madurawe RD; Moore CM; Khan MA; Khairuzzaman A Adv Drug Deliv Rev; 2017 Jan; 108():39-50. PubMed ID: 27001902 [TBL] [Abstract][Full Text] [Related]
26. Cyber-physical-based PAT (CPbPAT) framework for Pharma 4.0. Barenji RV; Akdag Y; Yet B; Oner L Int J Pharm; 2019 Aug; 567():118445. PubMed ID: 31226474 [TBL] [Abstract][Full Text] [Related]
27. Emerging Applications and Regulatory Strategies for Advanced Medicines Manufacturing - Towards the Development of a Platform Approach. Srai JS; Bauer P; Badman C; Bresciani M; Cooney CL; Florence A; Hausner D; Konstantinov K; Lee SL; Mascia S; Nasr M; Trout BL J Pharm Sci; 2024 Jul; 113(7):1701-1710. PubMed ID: 38663498 [TBL] [Abstract][Full Text] [Related]
28. Inkjet printing for pharmaceutics - A review of research and manufacturing. Daly R; Harrington TS; Martin GD; Hutchings IM Int J Pharm; 2015 Oct; 494(2):554-567. PubMed ID: 25772419 [TBL] [Abstract][Full Text] [Related]
30. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation. Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547 [TBL] [Abstract][Full Text] [Related]
31. Controlling drug release with additive manufacturing-based solutions. Patel SK; Khoder M; Peak M; Alhnan MA Adv Drug Deliv Rev; 2021 Jul; 174():369-386. PubMed ID: 33895213 [TBL] [Abstract][Full Text] [Related]
32. 3D Printing Methods for Pharmaceutical Manufacturing: Opportunity and Challenges. Warsi MH; Yusuf M; Al Robaian M; Khan M; Muheem A; Khan S Curr Pharm Des; 2018; 24(42):4949-4956. PubMed ID: 30520367 [TBL] [Abstract][Full Text] [Related]
33. Social aspects in additive manufacturing of pharmaceutical products. Lind J; Kälvemark Sporrong S; Kaae S; Rantanen J; Genina N Expert Opin Drug Deliv; 2017 Aug; 14(8):927-936. PubMed ID: 27892721 [TBL] [Abstract][Full Text] [Related]
34. The future of pharmaceutical quality and the path to get there. Yu LX; Kopcha M Int J Pharm; 2017 Aug; 528(1-2):354-359. PubMed ID: 28619448 [TBL] [Abstract][Full Text] [Related]
35. Regulatory Perspectives on Continuous Pharmaceutical Manufacturing: Moving From Theory to Practice: September 26-27, 2016, International Symposium on the Continuous Manufacturing of Pharmaceuticals. Nasr MM; Krumme M; Matsuda Y; Trout BL; Badman C; Mascia S; Cooney CL; Jensen KD; Florence A; Johnston C; Konstantinov K; Lee SL J Pharm Sci; 2017 Nov; 106(11):3199-3206. PubMed ID: 28655487 [TBL] [Abstract][Full Text] [Related]
36. Additive Manufacturing and Printing Approaches for the Development of Pharmaceutical Dosage Forms with Improved Biopharmaceutical Attributes. Kawish SM; Sharma S; Almalki WH; Alghamdi S; Afzal O; Kazmi I; Altamimi ASA; Al-Abbasi FA; Beg S; Ahmad FJ Curr Drug Metab; 2022; 23(8):616-629. PubMed ID: 35713126 [TBL] [Abstract][Full Text] [Related]
38. Provable Data Integrity in the Pharmaceutical Industry Based on Version Control Systems and the Blockchain. Steinwandter V; Herwig C PDA J Pharm Sci Technol; 2019; 73(4):373-390. PubMed ID: 30770485 [TBL] [Abstract][Full Text] [Related]
39. Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study. Tauqeer F; Myhr K; Gopinathan U Health Policy Plan; 2019 Jul; 34(6):440-449. PubMed ID: 31302684 [TBL] [Abstract][Full Text] [Related]